By PR Newswire, October 01, 2013, 11:42:00 AM EDT
LONDON, October 1, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
The U.S. equity market posted losses on Monday, September 30, 2013, with the S&P 500, the Dow Jones Industrial Average, and the NASDAQ Composite falling by 0.60%, 0.84%, and 0.27%, respectively. Shares in the healthcare sector mostly ended on a lower note as the broader market declined. The major movers in the sector included Celsion Corporation (NASDAQ:CLSN), Theravance Inc. (NASDAQ:THRX), Alkermes PLC (NASDAQ:ALKS), and Hospira Inc. (NYSE:HSP). All these companies are tracked by AAAResearchReports.com. Free technical research reports on CLSN, THRX, ALKS, and HSP can be accessed by signing up at:
Celsion Corp.'s stock fell sharply by 1.71% on Monday, tracking losses in the broader market. The company's shares vacillated between $1.15 and $1.19 before finishing the day at $1.15. A total of 0.85 million shares were traded, which is below the daily average volume of 2.03 million. Despite Monday's pullback, Celsion Corp.'s shares have gained 12.75% in the previous three months, outperforming the S&P 500 which has gained 4.69% during the same period. Furthermore, the company's stock is trading below its 50-day and 200-day moving averages of $1.21 and $2.30, respectively. Download free report on CLSN upon registration at:
Shares in Theravance Inc. fell sharply on Monday to close at $40.87, which is 1.18% lower than the previous day's closing price of $41.36. The company's shares oscillated between $40.50 and $41.27 during the trading session. A total of 0.81 million shares were traded, which is below the daily average volume of 0.88 million. The company's shares have gained 14.00% in the last one month and 6.07% in the previous three months, compared to a gain of 2.97% and 4.69% in the S&P 500 during the respective periods. Additionally, Theravance Inc.'s stock is trading above its 50-day and 200-day moving averages of $38.16 and $30.85, respectively. THRX technical report can be accessed for free by signing up at:
Alkermes PLC's stock ended slightly lower on Monday as the broader market finished on a negative note. The company's shares fluctuated between $33.01 and $33.80 before ending the day 0.06% lower at $33.62. A total of 0.83 million shares were traded, which is below the daily average volume of 1.14 million. The company's shares have gained 5.89% in the last one month and 17.22% in the previous three months, outperforming the S&P 500 which has advanced 2.97% and 4.69% during the respective periods. Moreover, Alkermes PLC's stock is trading above its 50-day and 200-day moving averages of $33.24 and $27.39, respectively. A free report on ALKS can be accessed by registering at:
Hospira Inc.'s stock rose 0.82% on Monday, reversing all of the losses from the previous trading session. The company's shares closed the day at $39.22 after oscillating between $38.45 and $39.26. A total of 0.67 million shares were traded, which is below the daily average volume of 0.86 million. The company's shares have gained 0.18% in the previous three trading sessions, compared to a loss of 0.66% in the S&P 500 during the same period. Further, Hospira Inc.'s stock is trading above its 200-day moving average of $35.17. Register with AAA Research Reports and download research on HSP for free at:
This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE AAA Research Reports